Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses

Molecular Therapy

Volumn 5, Issue 6, 2002, Pages 695-704

  Kanerva, Anna ^a   Wang, Minghui ^a   Bauerschmitz, Gerd J ^a   Lam, John T ^a   Desmond, Renee A ^a   Bhoola, Snehal M ^b   Barnes, Mack N ^b   Alvarez, Ronald D ^b   Siegal, Gene P ^a,c   Curiel, David T ^a   Hemminki, Akseli ^a,d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d and Radiation Oncology   (United States)

Author keywords

Adenovirus; Biodistribution; Cancer; Gene therapy; Ovarian cancer; Pseudotyping; Toxicity

Indexed keywords

ADENOVIRUS VECTOR; ARGINYLGLYCYLASPARTIC ACID; INTEGRIN; VIRUS RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; CANCER CELL; CELL ISOLATION; CONTROLLED STUDY; COXSACKIE VIRUS; FEMALE; GENE TRANSFER; HUMAN; HUMAN CELL; INOCULATION; LIVER; MOUSE; NONHUMAN; OVARY CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN MOTIF; RECEPTOR BINDING; SEROTYPE; VIRUS CAPSID; VIRUS INFECTIVITY; ADENOVIRUS; ANIMAL; C57BL MOUSE; CELL CULTURE; EPITHELIUM CELL; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; METABOLISM; OVARY TUMOR;

ADENOVIRIDAE; ANIMALIA; COXSACKIEVIRUS;

ADENOVIRIDAE; ANIMALS; EPITHELIAL CELLS; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED C57BL; OVARIAN NEOPLASMS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0035988998     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2002.0599     Document Type: Article

References (51)

1. Update on adenovirus and its vectors
2. Adenovirus in oncology: A viable option?
3. Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: What have we learned?
4. Loss of adenoviral receptor expression in human bladder cancer cells: A potential impact on the efficacy of gene therapy
5. Differential susceptibility of primary and established human glioma cells to adenovirus infection: Targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer
6. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells
7. Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells
8. Efficiency of adenovirus-mediated gene transfer to oropharyngeal epithelial cells correlates with cellular differentiation and human coxsackie and adenovirus receptor expression
9. Muscle-specific overexpression of the adenovirus primary receptor car overcomes low efficiency of gene transfer to mature skeletal muscle
10. A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): A phase I trial
11. Adenoviral-mediated suicide gene therapy for ovarian cancer
12. Multi-dose intraperitoneal (IP) rad/p53 (SCH58500) gene replacement combined with chemotherapy in heavily pretreated recurrent ovarian cancer is associated with prolonged survival
13. Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer
14. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism
15. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells
16. Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro
17. An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches
18. Detection of coxsackie-adenovirus receptor (CAR) immunoreactivity in ovarian tumors of epithelial derivation
19. The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures
20. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector
21. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
22. The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain
23. The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: A functional analysis of CAR protein structure
24. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction
25. Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment
26. An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression
27. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
28. Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid
29. Improved adenovirus vectors for infection of cardiovascular tissues
30. Adenovirus type 5 and 7 capsid chimera: Fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes
31. Highly efficient targeted transduction of undifferentiated human hematopoietic cells by adenoviral vectors displaying fiber knobs of subgroup B
32. Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain
33. An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites
34. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors
35. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages
36. Sequestration of adenoviral vector by Kupffer cells leads to a non-linear dose response of transduction in liver
37. Blood clearance rates of adenovirus type 5 in mice
38. Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesicle or intravenous administration to a mouse
39. Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector
40. Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ
41. Adenoviral gene delivery can inactivate Kupffer cells: Role of oxidants in NF-κB activation and cytokine production
42. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia
43. Improved adenoviral vectors for gene therapy and vaccination
44. Immune response to recombinant capsid proteins of adenovirus in humans: Antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity
45. A controlled trial of intratumoral ONYX-015, a selectively replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
46. Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors
47. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
48. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
49. Evidence for gene transfer and expression of Factor IX in haemophilia B patients treated with an AAV vector
50. Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications